News und Analysen
Apple's $3 Trillion Valuation May Be Gone for Good
Shares of Apple (NASDAQ: AAPL) slipped last week following a quarterly report that was mostly bad news. Revenue slumped, operating income was down, and the iconic iPhone suffered a sales decline
Is Sage Therapeutics a Contrarian Buy?
Monday was a dark day for Sage Therapeutics (NASDAQ: SAGE), a company that focuses on developing therapies for brain disorders. The stock plummeted by more than 53% after the company revealed that
Meta Platforms Stock Is a Buy on Solid Earnings and AI Potential
Meta Platforms (NASDAQ: META) had a rough 2022. Rising interest rates, a poor ad market, and increased competition forced the company to lay off thousands of employees; the stock price plummeted
Why Alphabet Investors Should Be Excited About Google Cloud
The cloud market is competitive, but Google Cloud is quickly making a name for itself. With an array of top-notch services and a dedication to innovation, it's no wonder it is gaining momentum. This
PayPal Is Great. Here's Why You Shouldn't Buy It
PayPal (NASDAQ: PYPL) recently reported its second-quarter 2023 financial results. Revenue totaled $7.3 billion (up 7% year over year), with adjusted diluted earnings per share coming in at $1.16
Where Will AMD Be in 1 Year?
Advanced Micro Devices (NASDAQ: AMD) stock set the market ablaze in 2023 with terrific gains of 78% so far this year, but it remains to be seen if the chipmaker's terrific run can continue following
Are the Good Times Over for Apple Stock?
Only one week ago, shares of Apple (NASDAQ: AAPL) were up more than 50% year to date. The giant tech stock was enjoying one of its best starts in a long time.
Then Apple announced its fiscal 2023
3 Stocks to Buy in August That Show No Signs of Slowing Down
The stock market has enjoyed a phenomenal 2023. And while it can seem counterintuitive to buy a stock at a higher price today than it was just a few months ago, sometimes that's the exact kind of
Why Boeing's Stock Remains a Buy Despite Mixed Results
Boeing's (NYSE: BA) recent results highlighted the case for the stock but perhaps not in the way many investors might think. In truth, they were mixed. However, Boeing's management has
Is AbbVie Still a Good Dividend Stock to Buy?
How do you know when a former favorite dividend stock is no longer one you should buy, or hold? Some would say it's time to look away as soon as the profits the company uses to make dividend
Microsoft: A Long-Term Investment in AI
It's no secret that Microsoft (NASDAQ: MSFT) is a powerhouse in the tech world. With a long history of groundbreaking innovations, this company has proven time and time again it's at the forefront
2 High-Yield Dividend Stocks to Buy on the Dip
Income-seeking investors tend to be drawn to high dividend yields. The higher the yield, the better a dividend becomes at generating income that can fund an investor's spending as well as beat
2 Excellent Tech Stocks to Buy For the Long Haul
The technology sector evolves rapidly, and companies that are unable to innovate -- or have no economic moat -- often end up being left behind. So, to find tech companies that can provide solid
1 Billion Reasons to Buy Apple Stock Hand Over Fist Now and Never Sell
This year has started in stark contrast to its predecessor. After enduring its worst performance in over a decade, the stock market has bounced back. The major market indexes have each gained 20% or
3 Stocks That Boosted Their Dividends by More Than 5%
Although the inflation rate has come down significantly in the past year to just 3% in June, prices are still substantially higher than they were just a few years ago. In an era where a dollar
This Recession Forecasting Tool Hasn't Been Wrong in 57 Years. Here's What It Says Comes Next for the U.S. Economy and Stock Market.
Wall Street has taken investors on quite the ride since this decade began. The COVID-19 pandemic led to a breakneck bear market crash in 2020 for the ageless Dow Jones Industrial Average (DJINDICES:
Is Starbucks an Excellent Dividend Stock to Buy for Passive Income Investors?
Fool.com contributor Parkev Tatevosian reviews Starbucks' (NASDAQ: SBUX) latest quarter and answers if it's a good choice for investors looking for passive income.
*Stock prices used were the
Why Marriott International Stock Inched Higher Today
Storied hotelier Marriott International (NASDAQ: MAR) had an up day on the stock market to kick off the trading week. The company's share price improved by nearly 1% thanks in no small part to an
Advance Auto Parts Offering Students a Chance to Win a ‘Fuel Ride to College’ and Free ‘Off-to-Campus’ In-Store Services
Advance Auto Parts (NYSE: AAP), a leading automotive aftermarket parts provider, announced today that it will help advance the education of incoming college freshmen, and ease their financial
Why BioNTech Stock Was Sinking Today
A monster revenue miss was the big reason for the widespread investor sell-off in BioNTech (NASDAQ: BNTX) stock on Monday. As of late-session trading that day, the once-hot biotech's share price had
Why KeyCorp Stock Jumped 33% in July
KeyCorp (NYSE: KEY) bounced back strong last month as its stock price climbed 33% in July, according to S&P Global Market Intelligence. KeyCorp, the holding company for Key Bank, is down about 31%
Microsoft's face reader
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
Microsoft wants
JPMorgan's AI intern
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
JPMorgan Chase
Why Zions Bancorp Stock Surged 42% in July
Zions Bancorporation (NASDAQ: ZION) rewarded investors in July as its stock price surged 42% higher in the month, according to S&P Global Market Intelligence. Zions Bancorp is still down about 22%
Why Sage Therapeutics Stock Is Crashing Today
Shares of Sage Therapeutics (NASDAQ: SAGE) were crashing 51.2% lower as of 11:27 a.m. ET on Monday. The huge sell-off came after the company and its partner, Biogen, announced following the market